Firm Settles $193 Million Qui Tam Whistleblower Suit

    Pennsylvania-based pharmaceutical company Endo Health Solutions has agreed to pay $193 million to settle claims that it engaged in illegal off-label marketing of its pain relief medication, Lidoderm. The company will pay $172 million to several states and the federal government to resolve whistleblower claims brought in the U.S. District Court for the … Continue reading Firm Settles $193 Million Qui Tam Whistleblower Suit